100 related articles for article (PubMed ID: 9229289)
1. Absence of endocardial lymphoid infiltrates (Quilty lesions) in nonheart transplant recipients treated with cyclosporine.
Barone JH; Fishbein MC; Czer LS; Blanche C; Trento A; Luthringer DJ
J Heart Lung Transplant; 1997 Jun; 16(6):600-3. PubMed ID: 9229289
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A.
Freimark D; Czer LS; Aleksic I; Ruan XM; Admon D; Blanche C; Trento A; Fishbein MC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1197-203. PubMed ID: 8719467
[TBL] [Abstract][Full Text] [Related]
3. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
[TBL] [Abstract][Full Text] [Related]
4. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
Marboe CC; Billingham M; Eisen H; Deng MC; Baron H; Mehra M; Hunt S; Wohlgemuth J; Mahmood I; Prentice J; Berry G
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S219-26. PubMed ID: 15993777
[TBL] [Abstract][Full Text] [Related]
5. Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection.
Radio SJ; McManus BM; Winters GL; Kendall TJ; Wilson JE; Costanzo-Nordin MR; Ye YL
Mod Pathol; 1991 Sep; 4(5):654-60. PubMed ID: 1836878
[TBL] [Abstract][Full Text] [Related]
6. Grade 2 cellular heart rejection: does it exist?
Fishbein MC; Bell G; Lones MA; Czer LS; Miller JM; Harasty D; Trento A
J Heart Lung Transplant; 1994; 13(6):1051-7. PubMed ID: 7865512
[TBL] [Abstract][Full Text] [Related]
7. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
[No Abstract] [Full Text] [Related]
8. FK506 vs. cyclosporin. Pathologic findings in 1067 endomyocardial biopsies.
Gajjar NA; Kobashigawa JA; Laks H; Espejo-Vassilakis M; Fishbein MC
Cardiovasc Pathol; 2003; 12(2):73-6. PubMed ID: 12684161
[TBL] [Abstract][Full Text] [Related]
9. "Quilty effect" in heart transplantation: is it related to acute rejection?
Pardo-Mindán FJ; Lozano MD
J Heart Lung Transplant; 1991; 10(6):937-41. PubMed ID: 1756159
[TBL] [Abstract][Full Text] [Related]
10. "Quilty" revisited: a 10-year perspective.
Joshi A; Masek MA; Brown BW; Weiss LM; Billingham ME
Hum Pathol; 1995 May; 26(5):547-57. PubMed ID: 7750939
[TBL] [Abstract][Full Text] [Related]
11. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
12. Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.
DeNofrio D; Rosengard BR; Reynolds C; Acker MA; Rook AH; Loh E
J Heart Lung Transplant; 1998 Oct; 17(10):1036-7. PubMed ID: 9811415
[No Abstract] [Full Text] [Related]
13. Quilty in biopsy is associated with poor prognosis after heart transplantation.
Hiemann NE; Knosalla C; Wellnhofer E; Lehmkuhl HB; Hetzer R; Meyer R
Transpl Immunol; 2008 Jul; 19(3-4):209-14. PubMed ID: 18617005
[TBL] [Abstract][Full Text] [Related]
14. Nature and significance of epicardial lymphoid infiltrates in cardiac allografts.
Luthringer DJ; Yamashita JT; Czer LS; Trento A; Fishbein MC
J Heart Lung Transplant; 1995; 14(3):537-43. PubMed ID: 7654737
[TBL] [Abstract][Full Text] [Related]
15. Significance of endocardial infiltrates (Quilty effect) in the transplanted heart.
Lozano MD; Pardo-Mindán FJ
J Heart Lung Transplant; 1994; 13(4):733-4. PubMed ID: 7947894
[No Abstract] [Full Text] [Related]
16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
17. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
[TBL] [Abstract][Full Text] [Related]
19. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
